Does OLAPARIB Cause Off label use? 777 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 777 reports of Off label use have been filed in association with OLAPARIB (Lynparza). This represents 4.3% of all adverse event reports for OLAPARIB.
777
Reports of Off label use with OLAPARIB
4.3%
of all OLAPARIB reports
212
Deaths
126
Hospitalizations
How Dangerous Is Off label use From OLAPARIB?
Of the 777 reports, 212 (27.3%) resulted in death, 126 (16.2%) required hospitalization, and 16 (2.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 777 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
Myelodysplastic syndrome (466)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which OLAPARIB Alternatives Have Lower Off label use Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL